Transcriptional changes in response to X chromosome dosage in the mouse: implications for X inactivation and the molecular basis of Turner Syndrome

<p>Abstract</p> <p>Background</p> <p>X monosomic mice (39,XO) have a remarkably mild phenotype when compared to women with Turner syndrome (45,XO). The generally accepted hypothesis to explain this discrepancy is that the number of genes on the mouse X chromosome which...

Full description

Bibliographic Details
Main Authors: Sargent Carole A, Bauer Julien, Ojarikre Andrew, Burgoyne Paul S, Lopes Alexandra M, Amorim António, Affara Nabeel A
Format: Article
Language:English
Published: BMC 2010-02-01
Series:BMC Genomics
Online Access:http://www.biomedcentral.com/1471-2164/11/82
id doaj-4c5d8ea4a3ff4fce93887638fb1287ad
record_format Article
spelling doaj-4c5d8ea4a3ff4fce93887638fb1287ad2020-11-25T00:46:36ZengBMCBMC Genomics1471-21642010-02-011118210.1186/1471-2164-11-82Transcriptional changes in response to X chromosome dosage in the mouse: implications for X inactivation and the molecular basis of Turner SyndromeSargent Carole ABauer JulienOjarikre AndrewBurgoyne Paul SLopes Alexandra MAmorim AntónioAffara Nabeel A<p>Abstract</p> <p>Background</p> <p>X monosomic mice (39,XO) have a remarkably mild phenotype when compared to women with Turner syndrome (45,XO). The generally accepted hypothesis to explain this discrepancy is that the number of genes on the mouse X chromosome which escape X inactivation, and thus are expressed at higher levels in females, is very small. However this hypothesis has never been tested and only a small number of genes have been assayed for their X-inactivation status in the mouse. We performed a global expression analysis in four somatic tissues (brain, liver, kidney and muscle) of adult 40,XX and 39,XO mice using the Illumina Mouse WG-6 v1_1 Expression BeadChip and an extensive validation by quantitative real time PCR, in order to identify which genes are expressed from both X chromosomes.</p> <p>Results</p> <p>We identified several genes on the X chromosome which are overexpressed in XX females, including those previously reported as escaping X inactivation, as well as new candidates. However, the results obtained by microarray and qPCR were not fully concordant, illustrating the difficulty in ascertaining modest fold changes, such as those expected for genes escaping X inactivation. Remarkably, considerable variation was observed between tissues, suggesting that inactivation patterns may be tissue-dependent. Our analysis also exposed several autosomal genes involved in mitochondrial metabolism and in protein translation which are differentially expressed between XX and XO mice, revealing secondary transcriptional changes to the alteration in X chromosome dosage.</p> <p>Conclusions</p> <p>Our results support the prediction that the mouse inactive X chromosome is largely silent, while providing a list of the genes potentially escaping X inactivation in rodents. Although the lower expression of X-linked genes in XO mice may not be relevant in the particular tissues/systems which are affected in human X chromosome monosomy, genes deregulated in XO mice are good candidates for further study in an involvement in Turner Syndrome phenotype.</p> http://www.biomedcentral.com/1471-2164/11/82
collection DOAJ
language English
format Article
sources DOAJ
author Sargent Carole A
Bauer Julien
Ojarikre Andrew
Burgoyne Paul S
Lopes Alexandra M
Amorim António
Affara Nabeel A
spellingShingle Sargent Carole A
Bauer Julien
Ojarikre Andrew
Burgoyne Paul S
Lopes Alexandra M
Amorim António
Affara Nabeel A
Transcriptional changes in response to X chromosome dosage in the mouse: implications for X inactivation and the molecular basis of Turner Syndrome
BMC Genomics
author_facet Sargent Carole A
Bauer Julien
Ojarikre Andrew
Burgoyne Paul S
Lopes Alexandra M
Amorim António
Affara Nabeel A
author_sort Sargent Carole A
title Transcriptional changes in response to X chromosome dosage in the mouse: implications for X inactivation and the molecular basis of Turner Syndrome
title_short Transcriptional changes in response to X chromosome dosage in the mouse: implications for X inactivation and the molecular basis of Turner Syndrome
title_full Transcriptional changes in response to X chromosome dosage in the mouse: implications for X inactivation and the molecular basis of Turner Syndrome
title_fullStr Transcriptional changes in response to X chromosome dosage in the mouse: implications for X inactivation and the molecular basis of Turner Syndrome
title_full_unstemmed Transcriptional changes in response to X chromosome dosage in the mouse: implications for X inactivation and the molecular basis of Turner Syndrome
title_sort transcriptional changes in response to x chromosome dosage in the mouse: implications for x inactivation and the molecular basis of turner syndrome
publisher BMC
series BMC Genomics
issn 1471-2164
publishDate 2010-02-01
description <p>Abstract</p> <p>Background</p> <p>X monosomic mice (39,XO) have a remarkably mild phenotype when compared to women with Turner syndrome (45,XO). The generally accepted hypothesis to explain this discrepancy is that the number of genes on the mouse X chromosome which escape X inactivation, and thus are expressed at higher levels in females, is very small. However this hypothesis has never been tested and only a small number of genes have been assayed for their X-inactivation status in the mouse. We performed a global expression analysis in four somatic tissues (brain, liver, kidney and muscle) of adult 40,XX and 39,XO mice using the Illumina Mouse WG-6 v1_1 Expression BeadChip and an extensive validation by quantitative real time PCR, in order to identify which genes are expressed from both X chromosomes.</p> <p>Results</p> <p>We identified several genes on the X chromosome which are overexpressed in XX females, including those previously reported as escaping X inactivation, as well as new candidates. However, the results obtained by microarray and qPCR were not fully concordant, illustrating the difficulty in ascertaining modest fold changes, such as those expected for genes escaping X inactivation. Remarkably, considerable variation was observed between tissues, suggesting that inactivation patterns may be tissue-dependent. Our analysis also exposed several autosomal genes involved in mitochondrial metabolism and in protein translation which are differentially expressed between XX and XO mice, revealing secondary transcriptional changes to the alteration in X chromosome dosage.</p> <p>Conclusions</p> <p>Our results support the prediction that the mouse inactive X chromosome is largely silent, while providing a list of the genes potentially escaping X inactivation in rodents. Although the lower expression of X-linked genes in XO mice may not be relevant in the particular tissues/systems which are affected in human X chromosome monosomy, genes deregulated in XO mice are good candidates for further study in an involvement in Turner Syndrome phenotype.</p>
url http://www.biomedcentral.com/1471-2164/11/82
work_keys_str_mv AT sargentcarolea transcriptionalchangesinresponsetoxchromosomedosageinthemouseimplicationsforxinactivationandthemolecularbasisofturnersyndrome
AT bauerjulien transcriptionalchangesinresponsetoxchromosomedosageinthemouseimplicationsforxinactivationandthemolecularbasisofturnersyndrome
AT ojarikreandrew transcriptionalchangesinresponsetoxchromosomedosageinthemouseimplicationsforxinactivationandthemolecularbasisofturnersyndrome
AT burgoynepauls transcriptionalchangesinresponsetoxchromosomedosageinthemouseimplicationsforxinactivationandthemolecularbasisofturnersyndrome
AT lopesalexandram transcriptionalchangesinresponsetoxchromosomedosageinthemouseimplicationsforxinactivationandthemolecularbasisofturnersyndrome
AT amorimantonio transcriptionalchangesinresponsetoxchromosomedosageinthemouseimplicationsforxinactivationandthemolecularbasisofturnersyndrome
AT affaranabeela transcriptionalchangesinresponsetoxchromosomedosageinthemouseimplicationsforxinactivationandthemolecularbasisofturnersyndrome
_version_ 1725264257922105344